![Novo Nordisk wins FDA approval for higher-dose Ozempic for adults with type 2 diabetes - Drug Discovery and Development Novo Nordisk wins FDA approval for higher-dose Ozempic for adults with type 2 diabetes - Drug Discovery and Development](https://www.drugdiscoverytrends.com/wp-content/uploads/2022/03/ozempic-pen.png)
Novo Nordisk wins FDA approval for higher-dose Ozempic for adults with type 2 diabetes - Drug Discovery and Development
![Novo Nordisk teaming up with startups for diabetes challenge, aiming to create new digital health tools – GeekWire Novo Nordisk teaming up with startups for diabetes challenge, aiming to create new digital health tools – GeekWire](https://cdn.geekwire.com/wp-content/uploads/2018/10/NovoNordiskImage-630x386.png)
Novo Nordisk teaming up with startups for diabetes challenge, aiming to create new digital health tools – GeekWire
Novo Nordisk India on Twitter: "Type 2 diabetes (T2DM) is a form of diabetes that is characterized by high blood sugar levels, the body's resistance to the action of insulin, and a
![Novo Nordisk Education Foundation introduces Mishti, a one stop solution for diabetes education – ThePrint – Novo Nordisk Education Foundation introduces Mishti, a one stop solution for diabetes education – ThePrint –](https://static.theprint.in/wp-content/uploads/2021/07/novo-nordisk-education-foundation-introduces-mishti-a-one-stop-solution-for-diabetes-education.jpg)
Novo Nordisk Education Foundation introduces Mishti, a one stop solution for diabetes education – ThePrint –
![Novo Nordisk promotes new GLP-1 receptor agonist to fight diabetes, obesity < Pharma < Article - KBR Novo Nordisk promotes new GLP-1 receptor agonist to fight diabetes, obesity < Pharma < Article - KBR](https://cdn.koreabiomed.com/news/photo/202204/13597_14138_1024.jpg)